VIEW PRESS RELEASE [PDF] 13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress…
Blog Archives
PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine
Tagged with: clinical trial, clinical trials, company, dbs, deep brain stimulation, development, efficacy, growth, homeview, mds, motion sensor, parkinson's disease, pd, tablet, technology, telemedicine, web app
PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of…
PRESS RELEASE: GLNT Tackles Continuous Monitoring of Essential Tremor with Launch of Multi-Site Clinical Study
VIEW PRESS RELEASE [PDF] April 5, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have launched a multi-site clinical study to assess continuous monitoring of essential tremor (ET) using their Kinesia technology platform. A preliminary study published…
PRESS RELEASE: GLNT Awarded Patent for Technology to Assess Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 8MAR2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have received allowance of claims from the U.S. Patent Office for an application covering their Movement Disorder Monitoring System and Method for quantitative assessment…